Athira Pharma, Inc. — Director's Dealing 2021

Jun 14, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2021-06-14

Reporting Person: Lenington Rachel (Chief Technology Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
No securities are beneficially owned.	$0.00		Not Applicable (0)		Direct

Footnotes

F1: Not applicable.